Healthcare Providers

Bristol-Myers Squibb provides the following information and resources for healthcare professionals, to assist with caring for patients and researching innovative medicines.


Medicine vials
Our Medicines
Our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

Resources by Condition

Education is the first step in fighting illness and serious disease. Stay informed on the resources and tools to help you in your journey.


Below is a list of resources to help patients and caregivers stay up to date with the latest information for various illnesses and diseases.


Medical Information & Services
Access medical information and resources for healthcare professionals.

Medical Information Contact Center

(toll free) 
Mon – Fri 9 AM – 5 PM ET

Report Side Effects/Adverse Reactions or Product Quality Complaints (Pharmacovigilance)

Visit our global site to report Side Effects, Product Quality Complaints, or Medical Information inquiries in other markets.


Clinical Trial Information for Researchers
Clinical trials and research are a critical part of bringing new medicines to patients.
Early Patient Access
Helping patients with serious diseases find information about access to innovative medicines.

Scientist with a microscope
Researchers & Partners
Find out how we're discovering and developing investigational medicines for patients.
Scientist filling a vial
Independent Research
Bristol-Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet needs surrounding our products and therapeutic areas.

We consider requests from independent investigators who share our goal.

Looking for Information on Investigator-sponsored Research, or Compound, Technology, and Data Sharing Requests?

Man drawing on a dry-erase board
Transparency
We are committed to conducting business with the highest integrity and will continue to increase transparency so we can share information with our patients, peers, and shareholders.